Jiangsu Vcare Pharmaceutical Technology Co., Ltd

This study tests a new tablet called VC005 for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 420 adults aged 18 to 70 will take the drug or a placebo for 12 weeks to see if it reduces symptoms by at least 20%. The goal i…

This study tests a new tablet called VC005 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can reduce the size of these patches on the face over 24 weeks. About 120 adults aged 18 to 70 will take part, and …